Clinical Trial Update: Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating andecaliximab in adults with cystic fibrosis has been terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Andecaliximab

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2018-07-05